Success Metrics

Clinical Success Rate
50.0%

Based on 2 completed trials

Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
2(40%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_2
3
60%
Ph phase_4
1
20%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)

Detailed Status

Terminated2
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (60.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

terminated240%
not_yet_recruiting120%
completed240%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_2

Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle

NCT06676475
terminatedphase_2

A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection

NCT04991688
terminatedphase_2

Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)

NCT00711087
completednot_applicable

Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients

NCT01817816
completedphase_4

Botulinum Toxin A Adult Gastrocnemius Muscle Study

NCT01278576

Clinical Trials (5)

Showing 5 of 5 trials
NCT06676475Phase 2

Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle

Not Yet Recruiting
NCT04991688Phase 2

A Prospective Pilot Study to Assess the Efficacy of BOTOX-A in Patients With Low Anterior Resection Syndrome (LARS>20) and Refractory Medical Treatment After Rectal Resection

Terminated
NCT00711087Phase 2

Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)

Terminated
NCT01817816Not Applicable

Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients

Completed
NCT01278576Phase 4

Botulinum Toxin A Adult Gastrocnemius Muscle Study

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5